来氟米特治疗风湿免疫性疾病的临床应用研究  

Clinical study of application of Leflunomide for rheumatic immunologic disease

作　　者：胡秋梅[1] 

机构地区：[1]邛崃市医疗中心医院,四川邛崃611500

出　　处：《当代医药论丛》2017年第13期15-16,共2页

摘　　要：来氟米特是一种新型的免疫制剂。该药最初主要用于预防和治疗器官移植手术后的排斥反应。随着人们对来氟米特研究的不断深入,其应用范围也在不断扩大。近年来,临床上使用该药治疗类风湿性关节炎、全身性红斑狼疮、强直性脊柱炎、干燥综合征及韦格纳肉芽肿等风湿免疫性疾病获得了很好的效果。本文主要总结目前临床上使用来氟米特治疗风湿免疫性疾病的情况。Leflunomide is a new type of immune preparations. Leflunomide was be applied in prevention and treatment of rejection. Application range of leflunomide became wide with deepening of research. In recent years, leflunomide was applied for treatment of rheumatic immunologic disease as rheumatoid arthritis, SLE, ankylosing spondylitis, Sjogren syndrome and Wegener＇s Granulomatosis and achieved good efficacy. We summarized clinical cases of application of leflunomide in this thesis.

关 键 词：来氟米特 风湿免疫性疾病 类风湿性关节炎 全身性红斑狼疮 强直性脊柱炎 干燥综合征 韦格纳肉芽肿 

分 类 号：R593.2[医药卫生—内科学]